Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)
CUSIP: 54948X109
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 141,152,375
- Total 13F shares
- 2,455,369
- Share change
- -247,138
- Total reported value
- $5,552,000
- Price per share
- $2.26
- Number of holders
- 23
- Value change
- -$914,258
- Number of buys
- 13
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 54948X109?
CUSIP 54948X109 identifies LUCD - Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 54948X109:
Top shareholders of LUCD - Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| LUMINUS MANAGEMENT LLC |
13F
|
Company |
0.54%
|
755,482
|
$2,538,000 | — | 31 Mar 2022 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.24%
|
333,717
|
$1,121,000 | — | 31 Mar 2022 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.22%
|
315,414
|
$1,060,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.22%
|
312,876
|
$1,051,000 | — | 31 Mar 2022 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.17%
|
241,972
|
$813,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
185,000
|
$622,000 | — | 31 Mar 2022 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.09%
|
133,000
|
$447,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
85,277
|
$286,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
67,565
|
$227,000 | — | 31 Mar 2022 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.04%
|
62,450
|
$209,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
56,693
|
$190,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
40,834
|
$137,000 | — | 31 Mar 2022 | |
| Verition Fund Management LLC |
13F
|
Company |
0.03%
|
36,166
|
$122,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
20,495
|
$69,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
13,800
|
$46,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
10,913
|
$37,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
9,142
|
$31,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
5,456
|
$18,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,548
|
$12,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
2,747
|
$9,000 | — | 31 Mar 2022 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
2,505
|
$8,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,367
|
$8,000 | — | 31 Mar 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
2,008
|
$7,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,484
|
$5,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,099
|
$4,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
910
|
$3,000 | — | 31 Mar 2022 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
756
|
$3,000 | — | 31 Mar 2022 | |
| Amalgamated Financial Corp. |
13F
|
Company |
0%
|
756
|
$3,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
822
|
$2,000 | — | 31 Mar 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
698
|
$2,000 | — | 31 Mar 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Mar 2022 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
390
|
$1,000 | — | 31 Mar 2022 | |
| Aster Angagaw |
3/4/5
|
Director |
—
class O/S missing
|
59,000
|
— | — | 18 Feb 2022 |
Institutional Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) as of Q2 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.